American Vietnamese Biotech Incorporation (HNX:AMV)

HNX:AMV Revenue

American Vietnamese Biotech Incorporation had revenue of 37.36B VND in the quarter ending June 30, 2026, a decrease of -2.46%. This brings the company's revenue in the last twelve months to 102.41B, down -69.04% year-over-year. In the year 2025, American Vietnamese Biotech Incorporation had annual revenue of 159.67B, down -48.55%.

• Revenue (ttm): 102.41B
• Revenue Growth: -69.04%
• P/S Ratio: 1.54
• Revenue / Employee: 994.23M
• Employees: 103
• Market Cap: 157.33B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	159.67B	-150.69B	-48.55%
Dec 31, 2024	310.35B	113.78B	57.88%
Dec 31, 2023	196.57B	-85.25B	-30.25%
Dec 31, 2022	281.82B	57.98B	25.90%
Dec 31, 2021	223.84B	62.41B	38.66%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 12, 2026

Data Sources Report a data error